EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access

Preeclampsia in the Context of COVID‐19: Mechanisms, Pathophysiology, and Clinical Outcomes

Guilherme M Nobrega iD, Brittany R Jones, Indira U Mysorekar iD, Maria Laura Costa

American Journal of Reproductive Immunology · 2024-08 · 92 (2)

DOI: 10.1111/aji.13915 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift American Journal of Reproductive Immunology, online erschienen am 12.08.2024. Verfasst von Guilherme M Nobrega und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil. Hauptthemen laut MEDLINE: COVID-19, Pre-Eclampsia, SARS-CoV-2, Pregnancy Complications, Infectious. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 137 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: CAPES Institutional Internationalization Program (CAPES/PrInt), Brazilian National Council for Scientific and Technological Development (CNPq), NIGMS NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The emergence of the severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) has led to the global COVID‐19 pandemic, significantly impacting the health of pregnant women. Obstetric populations, already vulnerable, face increased morbidity and mortality related to COVID‐19, aggravated by preexisting comorbidities. Recent studies have shed light on the potential correlation between COVID‐19 and preeclampsia (PE), a leading cause of maternal and perinatal morbidity worldwide, emphasizing the significance of exploring the relationship between these two conditions. Here, we review the pathophysiological similarities that PE shares with COVID‐19, with a particular focus on severe COVID‐19 cases and in PE‐like syndrome cases related with SARS‐CoV‐2 infection. We highlight cellular and molecular mechanistic inter‐connectivity between these two conditions, for example, regulation of renin–angiotensin system, tight junction and barrier integrity, and the complement system. Finally, we discuss how COVID‐19 pandemic dynamics, including the emergence of variants and vaccination efforts, has shaped the clinical scenario and influenced the severity and management of both COVID‐19 and PE. Continued research on the mechanisms of SARS‐CoV‐2 infection during pregnancy and the potential risk of developing PE from previous infections is warranted to delineate the complexities of COVID‐19 and PE interactions and to improve clinical management of both conditions.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19Pre-EclampsiaSARS-CoV-2Pregnancy Complications, InfectiousHumansPregnancyFemaleRenin-Angiotensin System

Stichwörter der Autor:innen

COVID‐19SARS‐CoV‐2complement system proteinsmaternal morbiditypreeclampsiarenin‐angiotensin systemtight junctions

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, School of Medical Sciences, University of Campinas, Campinas, São Paulo, Brazil.
  • Department of Medicine, Section of Infectious Diseases, Baylor College of Medicine, Houston, Texas, USA.
  • Department of Molecular Virology and Microbiology, Baylor College of Medicine, Houston, Texas, USA.
  • Huffington Center on Aging, Baylor College of Medicine, Houston, Texas, USA.

ORCID-Profile: Guilherme M Nobrega, Indira U Mysorekar

Förderung

  • CAPES Institutional Internationalization Program (CAPES/PrInt)
  • Brazilian National Council for Scientific and Technological Development (CNPq)
  • NIGMS NIH HHS
  • Brazilian Coordination of Superior Level Staff Improvement (CAPES)
  • São Paulo Research Foundation (FAPESP)
  • NICHD NIH HHS
  • NIH T32
  • NIH/NICHD

Zitieren

APA

Nobrega, G. M., Jones, B. R., Mysorekar, I. U., & Costa, M. L. (2024). Preeclampsia in the Context of COVID‐19: Mechanisms, Pathophysiology, and Clinical Outcomes. American Journal of Reproductive Immunology, 92(2). https://doi.org/10.1111/aji.13915

Vancouver

Nobrega GM, Jones BR, Mysorekar IU, Costa ML. Preeclampsia in the Context of COVID‐19: Mechanisms, Pathophysiology, and Clinical Outcomes. American Journal of Reproductive Immunology. 2024;92(2). doi:10.1111/aji.13915

BibTeX
@article{Nobrega2024,
  author = {Nobrega, Guilherme M and Jones, Brittany R and Mysorekar, Indira U and Costa, Maria Laura},
  title = {Preeclampsia in the Context of COVID‐19: Mechanisms, Pathophysiology, and Clinical Outcomes},
  journal = {American Journal of Reproductive Immunology},
  year = {2024},
  volume = {92},
  number = {2},
  doi = {10.1111/aji.13915}
}
Kostenlos starten →